Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: respiratory failure; hypertensive encephalopathy; vascular dementia; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, Safety Report Unique Identifier HU-OGYI-291521. This is a report received from the regulatory authority. Regulatory authority report number HU-OGYI-291521. An 80-year-old male patient received BNT162B2 (COMIRNATY), dose 1 intramuscularly in the left arm on 28Jan2021 (lot number: EJ6134) at 0.3ml, single dose for COVID-19 immunisation. Medical history included ongoing Parkinson''s disease, ongoing enlarged prostate, ongoing hypertension, ongoing dementia, ongoing arteriosclerosis, and ongoing alcoholism. Concomitant medication was not reported. On 03Feb2021, the patient died. The autopsy was not performed. According to the patient''s death certificate, the direct cause of death was respiratory failure, indirect causes were hypertension, hypertensive encephalopathy, and vascular dementia. Other information: the patient lived in a nursing home at the time of the vaccinations. On 27Jan2021, the Covid-19 rapid POC test was negative. In the physician''s opinion, the patient''s death was related to his underlying diseases. Outcome of events was fatal. Senders comments: The 80- year-old patient died 6 days after BNT162B2 vaccination. The cause of death was respiratory failure. Dechallenge and rechallenge were not applicable. The relationship between the reported death and the vaccine was considered unlikely. The case was serious due to fatal outcome. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Respiratory failure; hypertension; hypertensive encephalopathy; vascular dementia
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166